Cellular Implants…

1. Duke University – Doris Taylor – Autologous immature myoblasts (from thigh muscle).
2. McGill University – Ray Chiu – Autologous bone marrow stromal cells, myoblasts, growth factors.
3. Columbia University – Dan Burkhoff – heart failure model with upgraded measurement parameters for FDA IND – autologous immature myoblasts. Matching animal data with proposed human protocols. Designing human protocols.
4. Cleveland Clinic – Stephen Ellis – Immature myoblasts w/VEGF and Ang1 and perhaps NOS.
5. University of Arizona – Stu Williams - Endovascular delivery system feasibility, dermal fibroblast pellets to stimulate angiogenesis. Angiogenesis and Myogenesis combinations.
6. Georgetown University with University of California San Francisco – Michael Franz, Randy Lee – Autologous immature myoblast injections into myocardium "Effect on electrical and cellular activity of Heart – Is it safe?" – monophasic action potential monitoring.
7. Cell Therapy Foundation – Peter Law – Allogenic myoblast therapy with immunosuppresants.
8. University of Buffalo – Syde Taheri – skeletal muscle patch and omentum blood supply study.
9. U.C.L.A./U.S.C. – Sam Ahn, Greg Fontana – design of laproscopic delivery method.
10. Florida International University – Guylaine Senechal and team – in vitro testing of delivery systems.
11. William Beaumont Hospital – Laurace Townsend – Myocardial cell proliferation – culturing human myocardial cells for transplantation.
12. Santa Rosa Lab Bioheart – Robert Lashinski, Michael Lee – endovascular and laproscopic delivery system development.

Genotyping…

1. Ohio State University – Pascal Goldschmidt – discovery of cardiovascular risk factor-tailored therapy protocols based on genetic mapping.

TOP OF PAGE | GENOTYPING | MICROIMPLANTS